Literature DB >> 27778168

Visceral to subcutaneous fat ratio predicts acuity of diverticulitis.

Salvatore Docimo1, Young Lee2, Prav Chatani2, Ann M Rogers3, Frank Lacqua2.   

Abstract

INTRODUCTION: There is an association between obesity and more complicated diverticular disease. We hypothesize that this link may be due to an increased level of visceral fat rather than an elevated body mass index alone. Adipose tissue secretes inflammatory cytokines, and chronic inflammation may account for the link between obesity and a more severe presentation of diverticular disease. We have applied a quantitative measure of visceral fat content in a series of patients admitted with diverticulitis, comparing those who required emergent versus elective surgical procedures for diverticulitis.
METHODS: We performed a retrospective review of all adult patients who underwent emergent or elective surgery at our institution for diverticulitis from 2010 to 2014. Data were collected on demographics, comorbidities, operative findings, complications, and length of stay. Radiologic measurements of adiposity were obtained from preoperative CT scans. Visceral fat areas and subcutaneous fat areas were measured, and the V/S ratio was calculated.
RESULTS: Thirty-four patients underwent emergent and 32 patients underwent elective surgery. The mean age was 66.3 years for the emergent and 57.11 for the elective group (p = 0.04178). The perinephric, visceral, subcutaneous fat, and V/S ratio for the emergent group were 1.71, 185.22, 338.22, and 0.56 and were 1.11, 127.18, 295.28, and 0.46 for the elective group. The difference between the V/S ratio for each group was significant (p = 0.0238). The emergent group had an average LOS of 16.11 days compared to 5.15 for the elective group (p = <0.00001). The complication rate was significantly higher (p = 0.024) in the emergent group (n = 12, 35.2 %) compared to the elective group (n = 4, 12.5 %).
CONCLUSION: Our study demonstrates a clinically significant link between visceral fat and severity of presentation of diverticulitis. Patients with higher V/S fat ratios were more likely to require emergency surgery and have more complications and a longer LOS.

Entities:  

Keywords:  Diverticulitis; Obesity; Subcutaneous adiposity; Visceral adiposity

Mesh:

Year:  2016        PMID: 27778168     DOI: 10.1007/s00464-016-5290-2

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


  22 in total

1.  Effect of dietary fibre on stools and the transit-times, and its role in the causation of disease.

Authors:  D P Burkitt; A R Walker; N S Painter
Journal:  Lancet       Date:  1972-12-30       Impact factor: 79.321

2.  Computed tomography-based validation of abdominal adiposity measurements from ultrasonography, dual-energy X-ray absorptiometry and anthropometry.

Authors:  Anna M I Gradmark; Anders Rydh; Frida Renström; Emanuella De Lucia-Rolfe; Alison Sleigh; Peter Nordström; Soren Brage; Paul W Franks
Journal:  Br J Nutr       Date:  2010-04-07       Impact factor: 3.718

3.  Bariatric surgery reduces visceral adipose inflammation and improves endothelial function in type 2 diabetic mice.

Authors:  Hanrui Zhang; Yong Wang; Jing Zhang; Barry J Potter; James R Sowers; Cuihua Zhang
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-06-16       Impact factor: 8.311

4.  Visceral adiposity and the risk of metabolic syndrome across body mass index: the MESA Study.

Authors:  Ravi V Shah; Venkatesh L Murthy; Siddique A Abbasi; Ron Blankstein; Raymond Y Kwong; Allison B Goldfine; Michael Jerosch-Herold; João A C Lima; Jingzhong Ding; Matthew A Allison
Journal:  JACC Cardiovasc Imaging       Date:  2014-11-05

5.  Visceral Abdominal Obesity Measured by Computed Tomography is Associated With Increased Risk of Colonic Diverticulosis.

Authors:  Naoyoshi Nagata; Kayo Sakamoto; Tomohiro Arai; Ryota Niikura; Takuro Shimbo; Masafumi Shinozaki; Tomonori Aoki; Katsunori Sekine; Hidetaka Okubo; Kazuhiro Watanabe; Toshiyuki Sakurai; Chizu Yokoi; Junichi Akiyama; Mikio Yanase; Mitsuhiko Noda; Toshiyuki Itoh; Masashi Mizokami; Naomi Uemura
Journal:  J Clin Gastroenterol       Date:  2015 Nov-Dec       Impact factor: 3.062

6.  Subcutaneous and visceral adipose tissue gene expression of serum adipokines that predict type 2 diabetes.

Authors:  Katherine Samaras; Natalia K Botelho; Donald J Chisholm; Reginald V Lord
Journal:  Obesity (Silver Spring)       Date:  2009-12-17       Impact factor: 5.002

7.  Body mass index and diverticular disease: a 28-year follow-up study in men.

Authors:  Anders Rosemar; Ulf Angerås; Annika Rosengren
Journal:  Dis Colon Rectum       Date:  2007-12-22       Impact factor: 4.585

Review 8.  Obesity, inflammation, and insulin resistance.

Authors:  Steven E Shoelson; Laura Herrero; Afia Naaz
Journal:  Gastroenterology       Date:  2007-05       Impact factor: 22.682

9.  Relationship between disease location and age, obesity, and complications in Korean patients with acute diverticulitis: a comparison of clinical patterns with those of Western populations.

Authors:  Jae Hak Kim; Jae Hee Cheon; Sooyoung Park; Byung Chang Kim; Sang Kil Lee; Tae Il Kim; Won Ho Kim
Journal:  Hepatogastroenterology       Date:  2008 May-Jun

10.  The relationship of obesity to the complications of diverticular disease.

Authors:  C Dobbins; D Defontgalland; G Duthie; D A Wattchow
Journal:  Colorectal Dis       Date:  2006-01       Impact factor: 3.788

View more
  3 in total

Review 1.  Excessive Body Weight and Diverticular Disease.

Authors:  Stephan K Böhm
Journal:  Visc Med       Date:  2021-09-15

2.  Association Between Obesity and Weight Change and Risk of Diverticulitis in Women.

Authors:  Wenjie Ma; Manol Jovani; Po-Hong Liu; Long H Nguyen; Yin Cao; Idy Tam; Kana Wu; Edward L Giovannucci; Lisa L Strate; Andrew T Chan
Journal:  Gastroenterology       Date:  2018-04-01       Impact factor: 22.682

Review 3.  Recent advances in understanding and managing diverticulitis.

Authors:  Carola Severi; Marilia Carabotti; Alessia Cicenia; Lucia Pallotta; Bruno Annibale
Journal:  F1000Res       Date:  2018-06-29
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.